Thanks to our ongoing developments and dedicated partners, Goodwill Pharma Plc. now has a solid presence in Poland, Austria, and the Czech Republic, while also expanding into new markets in Greece, Georgia, and Mongolia.
These achievements clearly demonstrate our company’s consistent and deliberate effort to build international relationships and to make our innovative healthcare solutions accessible to more people worldwide.
Product Launch in the Polish Market
In recent days, two important milestones have been reached: the successful introduction of the Fortacell Immuno+ and Stilaxx product lines in Poland.
The training related to the Stilaxx launch was conducted by the business development team of Kosan Pharma, ensuring that local sales representatives are well-prepared and confident in representing the brand with professional expertise.
Representatives of the Polish subsidiary and the Hungarian parent company, Goodwill Pharma Plc., participated together in the cycle meeting, where enthusiasm and a shared goal were clearly evident: the successful market introduction of high-quality products.
The key to Goodwill Pharma’s international growth lies in the active and dedicated involvement of its subsidiaries, as they ensure that the company’s values and innovative solutions are introduced in each country with strong local professional support and cultural integration.
We wish our Polish colleagues every success with the launch – we are confident that our joint efforts will write yet another international success story!